Full Text View
Tabular View
No Study Results Posted
Related Studies
A Trial of OPC-41061 in Patients With Hepatic Edema - Investigation of the Safety of Treatment at 7.5 mg Beyond 7 Days and of the Effect of Dose Escalation to 15 mg
This study has been completed.
Study NCT01048788   Information provided by Otsuka Pharmaceutical Co., Ltd.

First Received on January 7, 2010.   Last Updated on August 24, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Cirrhosis
Additional conditions recognized in this trial
Fibrosis
Liver Cirrhosis
More general conditions related to this trial
Digestive System Diseases
Liver Diseases
Pathologic Processes
Interventions listed in this trial
OPC-41061
Sponsors listed in this trial
Otsuka Pharmaceutical Co., Ltd.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services